Regulatory oversight in the United States of vascularized composite allografts.
Vascularized composite allograft (VCA) transplantation is a medically acceptable treatment for the reconstruction of major tissue loss. The advent of VCA transplantation has spurred regulatory and policy development in the United States to address the multiple clinical, ethical and legal issues that must be considered for the practice of VCA donation and transplantation to develop within the existing framework of public trust and transparency vital to the success of donation and transplantation.
New England Organ Bank, Waltham, MA, USA.
Alexandra K
AK
Glazier
D064595:Composite Tissue Allografts; D006084:Graft Rejection; D006085:Graft Survival; D006801:Humans; D019520:Living Donors; D011640:Public Policy; D050378:T-Lymphocytes, Regulatory; D018183:Transplantation Chimera; D014184:Transplantation, Homologous; D014481:United States; D063986:Vascularized Composite Allotransplantation / Q000941:ethics / Q000331:legislation & jurisprudence* / Q000379:methods*
composite graft; donation; ethics; legal